Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-13-030682
Filing Date
2013-04-18
Accepted
2013-04-18 17:23:34
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A a13-9628_1s3a.htm S-3/A 561418
2 EX-4.5 a13-9628_1ex4d5.htm EX-4.5 432135
3 EX-4.6 a13-9628_1ex4d6.htm EX-4.6 440016
4 EX-23.1 a13-9628_1ex23d1.htm EX-23.1 2932
5 EX-23.2 a13-9628_1ex23d2.htm EX-23.2 4480
  Complete submission text file 0001104659-13-030682.txt   1442082
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-187801 | Film No.: 13769891
SIC: 2834 Pharmaceutical Preparations